Search research articles
Contact Us
Filters
Showing results (631-640 of 648) with videos related to
Page
of 65
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
August 2, 2025
Comprehensive first-in-human phase I/II study of FHND-9041 in patients with EGFR-mutated advanced non-small cell lung cancer
Liang Zeng, Fan Tong, Xingxiang Xu, et al.
The Lancet Regional Health. Western Pacific
|
December 8, 2025
Epidemiological analysis of infectious diseases in older people in China from 2014 to 2022: a population-based study
Sheng-Hong Lin, Chen-Long Lv, Meng-Jie Geng, et al.
Journal of Cancer
|
September 14, 2020
Risk Prediction for Locoregional Recurrence in Epidermal Growth Factor Receptor-Mutant Stage III-pN2 Lung Adenocarcinoma after Complete Resection: A Multi-center Retrospective Study
Qi-Wen Li, Bo Qiu, Wen-Hua Liang, et al.
Cancer Medicine
|
August 26, 2022
Comparison of the long-term outcomes of patients with hepatocellular carcinoma within the Milan criteria treated by ablation, resection, or transplantation
Ning-Ning Zhang, Jian Zheng, Ying Wu, et al.
Signal Transduction and Targeted Therapy
|
February 5, 2025
Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trial
Run-Cong Nie, Shu-Qiang Yuan, Ya Ding, et al.
Cancer Cell
|
September 14, 2016
Small-Molecule Targeting of E3 Ligase Adaptor SPOP in Kidney Cancer
Zhong-Qiang Guo, Tong Zheng, Baoen Chen, et al.
Frontiers in Oncology
|
March 22, 2021
Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis
Qitong Chen, Dengjie Ouyang, Munawar Anwar, et al.
Frontiers in Oncology
|
June 13, 2020
Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis
Qitong Chen, Dengjie Ouyang, Munawar Anwar, et al.
Cell
|
May 28, 2013
Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis
Min-Xian Qian, Ye Pang, Cui Hua Liu, et al.
Current Medical Science
|
August 9, 2020
Accumulated Clinical Experiences from Successful Treatment of 1377 Severe and Critically Ill COVID-19 Cases
Yong Gao, Hai-Bo Qiu, Shu Zhou, et al.
Page
of 65
Search research articles
Search
Showing results (631-640 of 648) with videos related to
Sort By:
Page
of 65
Lung Cancer (Amsterdam, Netherlands)
|
August 2, 2025
Comprehensive first-in-human phase I/II study of FHND-9041 in patients with EGFR-mutated advanced non-small cell lung cancer
Liang Zeng, Fan Tong, Xingxiang Xu, et al.
The Lancet Regional Health. Western Pacific
|
December 8, 2025
Epidemiological analysis of infectious diseases in older people in China from 2014 to 2022: a population-based study
Sheng-Hong Lin, Chen-Long Lv, Meng-Jie Geng, et al.
Journal of Cancer
|
September 14, 2020
Risk Prediction for Locoregional Recurrence in Epidermal Growth Factor Receptor-Mutant Stage III-pN2 Lung Adenocarcinoma after Complete Resection: A Multi-center Retrospective Study
Qi-Wen Li, Bo Qiu, Wen-Hua Liang, et al.
Cancer Medicine
|
August 26, 2022
Comparison of the long-term outcomes of patients with hepatocellular carcinoma within the Milan criteria treated by ablation, resection, or transplantation
Ning-Ning Zhang, Jian Zheng, Ying Wu, et al.
Signal Transduction and Targeted Therapy
|
February 5, 2025
Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trial
Run-Cong Nie, Shu-Qiang Yuan, Ya Ding, et al.
Cancer Cell
|
September 14, 2016
Small-Molecule Targeting of E3 Ligase Adaptor SPOP in Kidney Cancer
Zhong-Qiang Guo, Tong Zheng, Baoen Chen, et al.
Frontiers in Oncology
|
March 22, 2021
Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis
Qitong Chen, Dengjie Ouyang, Munawar Anwar, et al.
Frontiers in Oncology
|
June 13, 2020
Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis
Qitong Chen, Dengjie Ouyang, Munawar Anwar, et al.
Cell
|
May 28, 2013
Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis
Min-Xian Qian, Ye Pang, Cui Hua Liu, et al.
Current Medical Science
|
August 9, 2020
Accumulated Clinical Experiences from Successful Treatment of 1377 Severe and Critically Ill COVID-19 Cases
Yong Gao, Hai-Bo Qiu, Shu Zhou, et al.
Page
of 65